COVID Cicada Variant spreading rapidly worldwide, how dangerous it is, what are symptoms and situation in India
COVID Cicada Variant: A new sub-variant of the coronavirus—BA.3.2—is rapidly spreading across the globe; scientists have named it "Cicada." Originating in South Africa, this dangerous variant has now reached 23 countries worldwide, including the United States and Europe. The presence of over 70 mutations within it could make it significantly more infectious and challenging than all previous variants. In light of this new threat posed by the COVID Cicada variant, health experts are advising the entire world to remain vigilant.
Was first identified in S Africa
The Cicada variant was first identified in South Africa, after which it spread rapidly to many parts of the world in a very short time. Currently, cases have been detected in 25 U.S. states, and its presence has been confirmed in wastewater samples collected at airports there. Due to this rapid rate of spread, health experts have placed it in the special category of "Variant Under Watch."
Variant may be capable of evading body's immune system
The most striking feature of this new variant is the unusually high number of mutations found within it—estimated to be between 70 and 75. According to scientists, these mutations are primarily located in the virus's spike protein, which facilitates its entry into human cells. This is why the variant may be capable of evading the body's immune system as well as existing vaccines.
Key symptoms
Patients infected with the Cicada variant primarily exhibit symptoms such as a sore throat, extreme fatigue, and high fever. In some instances, coughing and body aches have also been reported, while in rare cases, night sweats have also been observed. If an individual experiences symptoms such as skin rashes or a loss of taste, they should get tested immediately.
Severe complications not observed
The good news is that, although the Cicada variant is spreading very rapidly, severe complications have not been observed in infected patients. According to reports received thus far, most cases range from mild to moderate in severity, and hospitalization rates remain stable. Experts state that it has not yet fully established itself as the dominant strain globally.
Situation in India
In the Indian context, a reassuring fact is that, for the time being, not a single active case of the Cicada variant has been reported in the country. However, given the risks associated with international travel, the threat of its spread within India remains ever-present; consequently, the Ministry of Health remains on high alert. Experts believe that the vaccination coverage already achieved across India's large population will help mitigate the risk of severe illness and fatalities.